Clinical trials: Mucus Clearance
Cystic Fibrosis
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
Mucus clearance is impaired in cystic fibrosis. Inhaled surfactants may reduce adhesive forces between mucus and airway surfaces and improve mucus clearance. This in turn my improve lung health.
- Trial name
- NCT00934362
- Testing
- Lucinactant first
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- University of North Carolina, Chapel Hill
Airway Secretion Clearance
Evaluation of High-Frequency Chest Wall Oscillation
To compare the outcomes of patients treated with the Vest and conventional chest physiotherapy to determine if the Vest provides equivalent therapy
- Trial name
- NCT00717873
- Testing
- Airway clearance Device
- Where
- United States
- Volunteers
- 105 people
- Sponsor
- Hill-Rom
Cystic Fibrosis
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
Previous work demonstrated that inhaled hypertonic saline (HS) reduces exacerbation frequency and improves lung function in adults with cystic fibrosis (CF).
- Trial name
- NCT01031706
- Testing
- Hypertonic Saline
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- University of North Carolina, Chapel Hill
Pulmonary Disease
Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function
The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.
- Trial name
- NCT00881335
- Testing
- flutter mucus clearance device
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Tongji University